About

The OMERS Private Equity legal team consists of managing director of legal Chantal Thibault, three directors, one associate and one legal assistant. One of the team’s directors, Stephanie Brady, is based in OMERS’ London, UK office whilst all other team members are based in Toronto. The team supports the company’s business and investment activities across four offices, which are in Toronto, London, New York and Singapore, and plays an integral role in all the private equity investment activities of OMERS. Thibault identifies that the team has ’gained the trust of our investment teams by providing timely, pragmatic and sound advice at all phases of the investment lifecycle. Our investment teams look to us for knowledge of market practices, to liaise with our tax, finance and accounting colleagues and to bring a consistent approach to legal matters across our portfolio’. In 2018, the team expanded its global experience by executing its first platform investment in Continental Europe, with the €670m acquisition of Trescal, a leading French international specialist for calibration services. This acquisition builds on the team’s extensive M&A experience in Canada, the US and the UK. Shortly following the opening of the new OMERS office in Singapore this year, the team assisted with two new cornerstone investments with Asian fund managers. This experience served as an excellent introduction to a region in which OMERS plans to become much more active. OMERS Private Equity set a new record for capital deployment in 2018 with four new platform acquisitions and several material add-on acquisitions within the company’s portfolio. The team sold two portfolio companies and a legacy portfolio of fund investments. Other highlights the legal team worked on include the disposition of MatrixCare Holdings, an industry leading SaaS-based long-term post-acute care technology provider, at a valuation of US$750m; the disposition of Husky IMS International, a leading industrial technology provider to the plastics processing industry, at a valuation of US$3.85bn; and the acquisition of Paradigm Outcomes, a market leading provider of complex and catastrophic medical management to the US workers’ compensation industry. It also worked on the acquisition of Premise Health, a leading direct healthcare company in the US, and the acquisition of Alexander Mann Solutions, a leading provider of talent acquisition and management services, at a valuation of £820m.